Viewing Study NCT02640534

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2026-03-05 @ 7:28 AM
Study NCT ID: NCT02640534
Status: TERMINATED
Last Update Posted: 2023-06-27
First Post: 2015-12-22
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone
Sponsor: Swiss Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer of the Prostate View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prostate cancer View
None Cancer of the prostate View
None Metformin View
None Enzalutamide View
None Xtandi View
None castration resistant prostate cancer View
None phase II View
None Androgen deprivation therapy View